← Devis Benfaremo

Papers by Devis Benfaremo

Page 1 · newest first

1. Safety and effectiveness of tocilizumab in systemic sclerosis: a multicentre French-Italian studyRMD Open · 2026
2. Expert Perspectives: Defining and managing progressive pulmonary fibrosis in systemic sclerosisArthritis & Rheumatology · 2026
3. The role of integrated gastro-rheumatological care in IBD-associated Spondyloarthritis in achieving joint–gut remission: Four-year outcomes from the real-world SPIB cohortSeminars in Arthritis and Rheumatism · 2026
4. Exploring potential VEGF receptor 2 inhibitors: a molecular modeling and pharmacophore-based screening approachScientific Reports · 2026
5. Micro- and Macro-Vascular Disease in Systemic Sclerosis and Very Early SSc (VEDOSS): Results from a Monocentric Observational StudyBiomedicines · 2026
6. Systemic Sclerosis: A Key Model of Endothelial DysfunctionBiomedicines · 2025
7. Axial psoriatic arthritis in patients not fulfilling the back pain entry features of the ASAS Classification Criteria for Axial Spondyloarthritis: findings from the ATTRACT StudyLara D. Veeken · 2025
8. Hypogammaglobulinemia in patients affected by limited cutaneous systemic sclerosis: Case series and review of the literatureJournal of Scleroderma and Related Disorders · 2025
9. Pos0810 Therapeutic Choices-Efficacy of the Integrative Management and Patient-Reported Outcomes in Patients With Ibd-Associated Spondylarthritis: A 4-Year Observational Study (The Spib Cohort)Annals of the Rheumatic Diseases · 2024
10. Ab1195 Nintedanib Restores Endothelial Function in Patients With Systemic Sclerosis: Preliminary Findings of a Monocentric StudyAnnals of the Rheumatic Diseases · 2024
11. Speckle-tracking global longitudinal strain predicts death and cardiovascular events in patients with systemic sclerosisEuropean Heart Journal Open · 2024
12. Role of cognitive impairment and malnutrition as determinants of quality of life in patients with systemic sclerosisJournal of Scleroderma and Related Disorders · 2024
13. Skin ultrasound in systemic sclerosis: past, present and exciting futureRheumatology Advances in Practice · 2023
14. Adeno‐Associated Virus Type 5 Infection via PDGFRα Is Associated With Interstitial Lung Disease in Systemic Sclerosis and Generates Composite Peptides and Epitopes Recognized by the Agonistic Immunoglobulins Present in Patients With Systemic SclerosisArthritis & Rheumatology · 2023
15. The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patientsLara D. Veeken · 2023
16. Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter studyArthritis Research & Therapy · 2023
17. Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision MedicineInternational Journal of Molecular Sciences · 2023
18. Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling StudyInternational Journal of Molecular Sciences · 2023
19. Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre studyRMD Open · 2023
20. PDGF/PDGFR: A Possible Molecular Target in Scleroderma FibrosisInternational Journal of Molecular Sciences · 2022
21. SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective StudyFrontiers in Immunology · 2022
22. Systemic Sclerosis: From Pathophysiology to Novel Therapeutic ApproachesSHILAP Revista de lepidopterología · 2022
23. Current Take on Systemic Sclerosis Patients’ Vaccination RecommendationsVaccines · 2021
24. Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinicianExpert Review of Clinical Immunology · 2021
25. Long term prognosis and cardiovascular complications of patients with systemic sclerosis-related cardiomiopathyEuropean Heart Journal · 2021
26. Diagnosis and management of leukocytoclastic vasculitisInternal and Emergency Medicine · 2021
27. New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A ReviewRheumatology and Therapy · 2021
28. Putative functional pathogenic autoantibodies in systemic sclerosisEuropean Journal of Rheumatology · 2020
29. Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel DiseasesThe Journal of Rheumatology · 2020
30. Abnormal liver function tests predict transfer to intensive care unit and death in COVID‐19Liver International · 2020
31. Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritisLara D. Veeken · 2020
32. Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?Cells · 2019
33. Enteropathic spondyloarthritis: Results from a large nationwide database analysisAutoimmunity Reviews · 2019
34. Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet NeedsJournal of Immunology Research · 2019
35. Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the LiteratureCurrent Drug Safety · 2018
36. Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel DiseaseThe Journal of Rheumatology · 2018
37. Biologics in Inflammatory and Immunomediated ArthritisCurrent Pharmaceutical Biotechnology · 2017
38. Biologics in Inflammatory Immune-mediated Systemic DiseasesCurrent Pharmaceutical Biotechnology · 2017
39. Certolizumab pegol for the treatment of psoriasisExpert Opinion on Biological Therapy · 2017
40. Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren’s syndromeLara D. Veeken · 2016